Extraordinary leaps need solid foundations, part 1, w/Moderna CEO Stéphane Bancel

Extraordinary leaps need solid foundations, p...

‏التالي

Building a marketplace from scratch, with Hipcamp founder Alyssa Ravasio

Alyssa Ravasio loves using ‘coyote trickster energy’ to get more people to put down their technology. Her camping marketplace, Hipcamp, has grown into the largest source for booking campsites on public and private land. She talks with host Jeff Berman about scaling the company, l ...  عرض المزيد

Kalshi vs. Everyone: Co-Founder Luana Lopes Lara on the lawsuits and the long game

Prediction markets incentivize truth. Everything else incentivizes clickbait. That's the core argument Luana Lopes Lara makes for Kalshi — the prediction market platform she co-founded that has gone from $5 billion to $22 billion in valuation in under a year, and is now being sue ...  عرض المزيد

‏حلقات موصى بها

Stéphane Bancel: “The upside was changing humanity forever.”
Math & Magic: Stories from the Frontiers of Marketing with Bob Pittman

Moderna’s CEO Stéphane Bancel will go down in history for pioneering the Covid-19 vaccine. He sits down with Bob to recount the story of the pandemic from his perspective, from the moment he knew it would become an international disaster to the decision to throw out Moderna’s pla ...  عرض المزيد

Moderna and Flagship Pioneering: Noubar Afeyan
How I Built This with Guy Raz

In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. Noubar Afeyan fully understood those risks when he co-founded Moderna in 2010. He and his colleagues were looking for a w ...  عرض المزيد

Moderna CEO Talks New Drugs
Bloomberg Talks

Moderna CEO Stephane Bancel talks about the Moderna vaccine, drug prices, and future of the company with Bloomberg's Paul Sweeny and Matt Miller. See omnystudio.com/listener for privacy information. 

301: Biotech mega-rounds, a cancer vaccine setback & CEOs keep their promise
The Readout Loud

Oruka Therapeutics CEO Lawrence Klein joins us to discuss how his company raised its first round of financing before competing with major players in the inflammation space. We also discuss the latest news in the life sciences, including the end of the Amylyx ALS saga, another use ...  عرض المزيد